Influence of Antibiotic Susceptibility Patterns on Empiric Antibiotic Prescribing for Children Hospitalized With Community-acquired Pneumonia

被引:16
|
作者
Ambroggio, Lilliam [2 ]
Tabb, Loni Philip [2 ]
O'Meara, Timothy [3 ]
Sheffler-Collins, Seth [3 ]
McGowan, Karin L. [3 ,4 ,5 ,6 ]
Shah, Samir S. [1 ,7 ,8 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA
[2] Drexel Univ, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA
[4] Childrens Hosp Philadelphia, Clin Microbiol Lab, Philadelphia, PA 19104 USA
[5] Univ Penn, Dept Pathol, Sch Med, Philadelphia, PA 19104 USA
[6] Univ Penn, Dept Lab Med, Sch Med, Philadelphia, PA 19104 USA
[7] Cincinnati Childrens Hosp Med Ctr, Div Hosp Sci, Cincinnati, OH 45229 USA
[8] Univ Cincinnati, Dept Pediat, Coll Med, Cincinnati, OH 45229 USA
基金
美国国家卫生研究院;
关键词
pneumonia; child; bacterial drug resistance; Streptococcus pneumoniae; pediatric hospitals; LOGISTIC-REGRESSION;
D O I
10.1097/INF.0b013e3182489cc4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: The aim of this study was to determine the influence of pneumococcal penicillin-nonsusceptibility patterns on individual antibiotic prescription among 33 children's hospitals using a multilevel, random-intercept, logistic regression analysis. Methods: It was a multilevel cross-sectional study. The participants were children, 1-18 years of age, with community-acquired pneumonia (CAP) who were discharged in 2006. Hospital antibiotic susceptibility data were collected from surveys, and patient data were obtained from an administrative database. The primary exposure was the proportion of penicillin-nonsusceptible pneumococcal isolates reported in 2005 by each hospital. A secondary exposure included using the proportion of penicillin-resistant pneumococcal isolates to determine whether a threshold of susceptibility existed. Receipt of broad-spectrum empiric antibiotic therapy in 2006 (ie, antibiotics other than penicillins or aminopenicillins) was the main outcome measure. Results: Four thousand eight hundred eighty-eight children diagnosed with CAP were eligible. The proportion of penicillin-nonsusceptible isolates ranged from 9% to 70% across hospitals whereas the proportion of penicillin-resistant isolates ranged from 0% to 60%. Broad-spectrum antibiotics were prescribed to 93% of patients; 45% of patients received cephalosporin class antibiotics alone. There was no significant association between the proportion of pencillin-nonsusceptible pneumococcal isolates at individual hospitals and narrow-spectrum prescribing. However, every 10% increase in penicillin-resistant pneumococcal isolates was associated with a 39% increase in broad-spectrum antibiotic prescribing (adjusted odds ratio: 1.39; 95% confidence interval: 1.08-1.69). Conclusions: There was substantial variability in empiric antibiotic prescribing for CAP among children's hospitals in the United States. High-levels (ie, resistant) but not modest-levels (ie, intermediate susceptibility) of penicillin resistance were associated with broad-spectrum antibiotic prescribing.
引用
收藏
页码:331 / 336
页数:6
相关论文
共 50 条
  • [21] International Guideline concordance of empiric antibiotic use in community-acquired pneumonia
    Pascual Guardia, Sergi
    Marin-Corral, Judith
    Carugati, Manuela
    Aliberti, Stefano
    Sibila, Oriol
    Sanz, Francisco
    Sotgiu, Giovanni
    Marcos, Pedro J.
    Kolditz, Martin
    Restrepo, Marcos, I
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [22] Impact of clinical decision support on empirical antibiotic prescribing for children with community-acquired pneumonia
    Mostaghim, Mona
    Snelling, Tom
    McMullan, Brendan
    Ewe, Yean H.
    Bajorek, Beata
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2019, 55 (03) : 305 - 311
  • [23] Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults
    Robenshtok, E.
    Shefet, D.
    Gafter-Gvili, A.
    Paul, M.
    Vidal, L.
    Leibovici, L.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (01):
  • [24] Antibiotic treatment duration for community-acquired pneumonia in children
    Singla, Shalini
    Sih, Kendra
    Goldman, Ran D.
    CANADIAN FAMILY PHYSICIAN, 2023, 69 (06) : 400 - 402
  • [25] Duration of Antibiotic Therapy for Community-Acquired Pneumonia in Children
    Tamma, Pranita D.
    Cosgrove, Sara E.
    CLINICAL INFECTIOUS DISEASES, 2012, 54 (06) : 883 - U167
  • [26] Empiric antibiotic coverage of atypical pathogens for community acquired pneumonia in hospitalized adults
    Shefet, D
    Robenshtock, E
    Paul, M
    Leibovici, L
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (02):
  • [27] Impact of Clinician Feedback Reports on Antibiotic Use in Children Hospitalized With Community-acquired Pneumonia
    Chiotos, Kathleen
    Dutcher, Lauren
    Grundmeier, Robert W.
    Meyahnwi, Didien
    Lautenbach, Ebbing
    Neuhauser, Melinda M.
    Hicks, Lauri A.
    Hamilton, Keith W.
    Li, Yun
    Szymczak, Julia E.
    Muller, Brandi M.
    Congdon, Morgan
    Kane, Emily
    Hart, Jessica
    Utidjian, Levon
    Cressman, Leigh
    Jaskowiak-Barr, Anne
    Gerber, Jeffrey S.
    CLINICAL INFECTIOUS DISEASES, 2025, 80 (02) : 263 - 270
  • [28] Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia
    File, TM
    Garau, J
    Blasi, F
    Chidiac, C
    Klugman, K
    Lode, H
    Lonks, JR
    Mandell, L
    Ramirez, J
    Yu, V
    CHEST, 2004, 125 (05) : 1888 - 1901
  • [29] Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia
    Frei, Christopher R.
    Restrepo, Marcos I.
    Mortensen, Eric M.
    Burgess, David S.
    AMERICAN JOURNAL OF MEDICINE, 2006, 119 (10): : 865 - 871
  • [30] Evidence-based medicine: Empiric antibiotic therapy in community-acquired pneumonia
    Read, RC
    JOURNAL OF INFECTION, 1999, 39 (03) : 171 - 178